Clinical trial
Immunization Against oxLDL in Patients With Lysosomal Lipid Diseases and Associated Metabolic Disorders
NCT02707211 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunization Against oxLDL in Patients With Lysosomal Lipid Diseases and Associated Metabolic Disorders
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 30, 2016
- Completion date
- February 28, 2017
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.